Article info
PDFResearch Article
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
- ↵a heinz.laeubli{at}unibas.ch
- ↵b catharina.balmelli{at}usb.ch
- ↵c l.kaufmann{at}student.tugraz.at
- ↵d michal.stanczak{at}unibas.ch
- ↵e m.syedbasha{at}unibas.ch
- ↵f d.vogt{at}unibas.ch
- ↵g astrid.hertig{at}usb.ch
- ↵h beat.mueller{at}luks.ch
- ↵i oliver.gautschi{at}luks.ch
- ↵j frank.stenner{at}usb.ch
- ↵k alfred.zippelius{at}usb.ch
- ↵l adrian.egli{at}usb.ch
- ↵m +41 61 265 50 74 sacha.rothschild{at}usb.ch
Citation
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
Publication history
- Received February 27, 2018
- Accepted May 9, 2018
- First published May 22, 2018.
Online issue publication
February 10, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© The Author(s).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.